Anthera Pharmaceuticals Return on Assets
Anthera Pharmaceuticals Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 30, 2012 | -130.5% |
| March 31, 2012 | -119.2% |
| Dec. 31, 2011 | -111.2% |
| Sept. 30, 2011 | -91.23% |
| June 30, 2011 | -80.78% |
| March 31, 2011 | -72.38% |
| Dec. 31, 2010 | -79.19% |
| Sept. 30, 2010 | -72.70% |
| June 30, 2010 | -96.57% |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
ANTH Return on Assets Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 10.07% |
| Pfizer | 7.88% |
| Tetraphase Pharmaceuticals |
ANTH Return on Assets Range, Past 5 Years
| Minimum | -130.5% | Jun 2012 |
| Maximum | -72.38% | Mar 2011 |
| Average | -94.87% |
